Today: 30 April 2026
RTX stock alert: Trump’s buyback clampdown hangs over defense names as $130 mini-tender deadline nears
10 January 2026
1 min read

RTX stock alert: Trump’s buyback clampdown hangs over defense names as $130 mini-tender deadline nears

New York, January 9, 2026, 19:15 ET — After-hours

  • RTX shares rose about 0.7% in late trading on Friday
  • Trump’s order would tie buybacks, dividends and executive pay to weapons delivery performance
  • RTX urged holders to reject a $130 mini-tender offer expiring Jan. 12; earnings due Jan. 27

RTX Corp shares rose about 0.7% to $188.50 in after-hours trade on Friday as investors kept sorting through a Trump administration order that could curb dividends and share buybacks at major defense contractors.

The order matters because cash returns are a big part of the defense-stock pitch. Lockheed Martin, Northrop Grumman, General Dynamics, L3Harris and RTX paid roughly $8 billion in dividends over the last 12 months and bought back about $10 billion of stock, Morgan Stanley data compiled by Reuters showed. Buybacks are when a company repurchases its own shares, often lifting earnings per share by shrinking the share count.

Contractors have been calling lawyers, and the industry is bracing for a messy rollout. “Ultimately, this announcement results in more questions than answers,” TD Cowen analyst Roman Schweizer wrote, adding he expected the Pentagon to clarify definitions and benchmarks. Breaking Defense

RTX also flagged a separate, smaller issue for shareholders this week. The company said it received notice of an unsolicited “mini-tender” offer from Tutanota LLC to buy up to 500,000 RTX shares at $130 each, and urged holders not to tender because the price is below the market and the offer carries conditions; it is currently scheduled to expire at 5:00 p.m. EST on Jan. 12. Mini-tender offers typically target less than 5% of a company’s shares, sidestepping some SEC disclosure and procedural rules, RTX said. RTX

Defense stocks have been jumpy since Trump’s comments hit midweek, but some names rallied into the weekend. Lockheed and Northrop each rose more than 4% in Friday’s session, while RTX gained about 0.7%, MarketWatch data showed.

But the downside case is straightforward: if the administration uses contract leverage aggressively — even before courts weigh in — the threat of delayed payments, tougher terms or lost work could change how investors value the sector’s steady cash-return model. The bigger risk for RTX is not the paperwork. It is uncertainty around what “underperformance” means and how quickly Washington tries to enforce it.

Next up: investors will watch for any Pentagon guidance tied to the executive order, the Jan. 12 mini-tender deadline, and RTX’s fourth-quarter results on Jan. 27, when the company is due to give its 2026 outlook.

Stock Market Today

  • Cartier Heir Sentenced to 8 Years for $470M Drug Money Crypto Laundering Scheme
    April 30, 2026, 3:26 PM EDT. Maximilien de Hoop Cartier, descended from the Cartier jewelry family, was sentenced to eight years in federal prison for running an unlicensed cryptocurrency exchange that laundered over $470 million in drug money. The scheme involved shell companies posing as software firms and broke transactions into smaller amounts to evade bank detection. Cartier pleaded guilty to money transmission without a license and bank fraud conspiracy in Manhattan federal court. Authorities seized nearly $940,000 in 2021, and Cartier was ordered to forfeit over $2.3 million and multiple bank accounts. U.S. Attorney Jay Clayton condemned Cartier's exploitation of financial systems for laundering drug proceeds. Cartier also maintains a social media presence as a singer under the name 'Max Cartier.'

Latest article

Rezolve AI Stock Rises After Revenue Tops All of 2025 in 90 Days

Rezolve AI Stock Rises After Revenue Tops All of 2025 in 90 Days

30 April 2026
Rezolve AI reported $60 million in first-quarter revenue, surpassing its audited 2025 total of $46.8 million, based on unaudited accounts. Shares rose 4.9% after the update. The company reaffirmed its $360 million 2026 revenue target and said it can reach profitability without new equity sales. Commerce.com, which rejected Rezolve’s all-stock takeover offer, adopted a poison pill defense.
Option Care Health Stock Plunges After 2026 Revenue Cut Exposes Chronic-Therapy Drag

Option Care Health Stock Plunges After 2026 Revenue Cut Exposes Chronic-Therapy Drag

30 April 2026
Option Care Health shares fell 28% to $19.44 after the company cut its 2026 revenue forecast and reported first-quarter sales of $1.35 billion, missing estimates. The company now expects 2026 revenue of $5.675–$5.775 billion, down from a prior range of $5.8–$6.0 billion, citing pressure in its chronic inflammatory disease portfolio. Adjusted profit guidance was unchanged.
Stellantis N.V. Stock Slides: Q1 Profit Rebound Leaves One Big Cash-Flow Question

Stellantis N.V. Stock Slides: Q1 Profit Rebound Leaves One Big Cash-Flow Question

30 April 2026
Stellantis reported a first-quarter net profit of €377 million, reversing a €387 million loss a year earlier, aided by a €400 million expected U.S. tariff refund. Industrial free cash flow remained negative at €1.92 billion. Shares fell 6.4% to €6.22 after the results. CEO Antonio Filosa faces pressure ahead of a May 21 investor day to present a stronger turnaround plan.
Ondas (ONDS) stock slips after hours after $1B share-and-warrant deal — what to know next week
Previous Story

Ondas (ONDS) stock slips after hours after $1B share-and-warrant deal — what to know next week

Singapore Airlines stock slips again as oil firms; Feb 24 update looms
Next Story

Singapore Airlines stock slips again as oil firms; Feb 24 update looms

Go toTop